The aflo™ platform (patent pending) combines a device, user co-designed App, clinician portal and a cloud-based, AI-driven data analytics tool with next-generation software to deliver real-time inhaler technique, symptoms and trigger identification. Clinical testing is underway in 2022 with a final product available in 2023.